AzTrials
AzTrials

StrokeNCT06563206

Exergame and Robotic Therapy Impact on Tenascin-C and Functional Outcome on Stroke Patients

A study testing Exergame, Robotic and Conventional in people with Stroke and Paralysis Arm, run by Hasanuddin University at 2 sites in Indonesia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This clinical trial aims to compare the effectiveness of Robotic versus Exergame versus Standard therapy to improve hand function among post-stroke patients. The main questions it aims to answer are: 1, Effectiveness of interventions in functional outcome recovery across time 2. Read more about this study

Who is it for?
Any age
Conditions the study is for
Stroke, Paralysis Arm
What is being tested?
Exergame, Robotic and Conventional
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
2 sitesIndonesia
Study dates
1 Oct 2023to 1 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients after ischemic or hemorrhagic stroke
  • stable hemodynamics and neurologic state.
  • Patients have never undergone treatment with any intervention
  • Able to watch television with or without glasses from a distance of 1 meter.
  • Patients can understand informed consent to participate in research

Who cannot join

  • Patients with a history of seizures or epilepsy.
  • Patients with severe cognitive disorders that can interfere with research objectives (MMSE score <24).
  • Patients with field deficits or severe vision disorders.
  • The patient is unable to sit upright without help.
  • Patients with significant pain in the affected upper limb.
  • Patients with significant sensory decreases in the upper limb that are affected
Show all 12Show fewer
  • Patients with other medical conditions (musculoskeletal, neuromuscular, cardio respiration) are uncontrolled and are at risk of disrupting the ability to exercise.
  • Dropout Criteria
  • Patients who were declared dead
  • Refusing to continue the training session or less < 50% of all sessions.
  • Experiencing hemodynamic and neurological disorders during the training program process.
  • Experiencing cybersickness twice in successive training sessions

Trial locations and contacts

2 sites in 1 country.

Indonesia2 sites, 2 recruiting
  • Hasanuddin University, Faculty of Medicine

    Makassar, South Sulawesi, 90245

    Auliyah Fadly, MD, +62411591331, muh.auliyah.fadly@gmail.com

    Rumaisah Hasan, MD

    Recruiting
  • Wahidin Sudirohusodo General Hospital

    Makassar, South Sulawesi, 90245

    Auliyah Fadly, +62 411 583333, muh.auliyah.fadly@gmail.com

    Rumaisah Hasan, MD

    Recruiting

Other trials in Indonesia

About this study

Official title: Comparison of Tenascin-C Value Rates and Functional Outcomes Between Exergame Therapy and Robotic Therapy in Post-Stroke Patients

This clinical trial aims to compare the effectiveness of Robotic versus Exergame versus Standard therapy to improve hand function among post-stroke patients. The main questions it aims to answer are:

1, Effectiveness of interventions in functional outcome recovery across time 2. Effectiveness of interventions in affecting Tenascin-C level 3. Clinical outcome difference between all interventions

Participants will be allocated into three groups, either a robotic group, exergame group as the main interventions, and standard rehabilitation group as the active comparator. A serial follow-up will be conducted to assess the selected clinical outcome and differences in outcome

Read the detailed description

1, Research design This research is an experimental study with a randomized controlled trial research design.

  1. Study Setting The research will be carried out among post-stroke patients at two teaching hospitals and one physical rehabilitation center in Makassar
  2. Procedure
  3. Standard Rehabilitation Comprehensive medical management and rehabilitation of disabilities caused by stroke through the neurorehabilitation approach with the aim of optimizing recovery and or modifying existing remaining symptoms so that stroke people are able to carry out functional activities independently, can adapt to the environment and achieve quality life
  4. Exergame Physical exercise of the entire body carried out through active video games that require gross motor skills, visual-spatial coordination, balance, and energy expenditure that are proportional to the intensity of moderate physical activity
  5. Robotic Therapy Mirror therapy intervention uses the help of robot exoskeletal to move the sick side. A set of mirror therapy exercises, using Syrebo robotics, using 1 set of Activity Daily Living (ADL) training during therapy, and using a mirror that will reflect a healthy side shadow.
  6. Time frame the procedure will be conducted in parallel three times per week for a total of six weeks, with two measurements before and after six weeks of training
  7. Outcomes
  8. motoric ability of upper extremity using Fugl-Meyer Assessment for Upper Extremities (FMA-UE)
  9. Dexterity, coordination and response of finger using the Nine Hole Peg Test (NHPT)
  10. Hand motor strength with Handgrip dynamometer
  11. Level of Tenascin-C in blood serum before and after
  12. Case definition
  13. type of stroke determined by radiology imaging b. phase of stroke (acute, sub-acute or chronic) c. cognitive ability measured using mini-mental state examination (MMSE) d. Spasticity measured by the Modified Ashworth Scale (MAS)
  14. Procedure
  15. The data collected is primary data obtained in accordance with the inclusion criteria.
  16. Samples who are willing to become research subjects will undergo interviews, physical examinations, FMA-UE-Hand Motor Domain, handgrip and NHPT examinations. The interview questionnaire in this study will contain a list of patient identities including name, age, marital status, address, educational history, employment history, history of stroke, cognitive examination (MMSE), and self-reported visual ability.
  17. Measurement tools
  18. The FMA-UE-Hand Motor Domain scoring system is used to evaluate upper extremity motor function in patients with neurological disorders, such as stroke. The scoring system ranges from 0-14, with higher scores indicating better motor function. The FMA-UE-Hand Motor domain assessment system is broken down into several subscales, namely Mass Flexion and Extension movements, followed by functional movements of grasping (Grasp), including Hook Grasp, Thumb Adduction, Pincer Grasp, Cylinder Grasp, and Spherical Grasp. The assessment will get a score of 0 = None or no movement, 1 = Partial or limited movement, and 2 = Full or perfect movement.
  19. The NHPT assessment consists of a square board with 9 pegs. At one end of the board, there is a hole for the peg, and at the other end, there is a shallow round plate for holding the peg. NHPT is performed by having the patient take pegs from a container, one at a time, and place them into the holes in a board, as quickly as possible. The patient must then remove the pegs from the holes, one at a time, and reinsert them into the housing. To practice and register initial scores, the test must be started with the unaffected upper limb. The board should be placed in the centre of the patient's body with the housing holding the pegs oriented toward the hand being tested. Only the hand being evaluated should perform the test. The non-evaluated hand is allowed to grip the edge of the board to provide stability. Patients are scored based on the time required to complete the test activity, recorded in seconds. The stopwatch must start from the moment the participant touches the first peg until the last peg touches the container. This assessment requires a board, of wood or plastic, with 9 holes (10 mm diameter, 15 mm depth), spaced 32 mm or 50 mm apart and a stopwatch.
  20. Tenascin-C To perform an ELISA for Tenascin-C, the procedure involves preparing samples and standards according to the kit instructions. The samples and standards are added to wells pre-coated with Tenascin-C-specific antibodies and incubated to facilitate binding. Following incubation, the wells are washed to remove any unbound substances. A detection antibody, conjugated with an enzyme, is then added and incubated. After additional washing, a substrate solution is introduced, causing a color change proportional to the amount of Tenascin-C present. The reaction is stopped with an acid solution, and the optical density is measured using a plate reader. The Tenascin-C concentration in the samples is determined by comparing the optical density readings to a standard curve. Typically, Tenascin-C levels are reported in pg/mL, and the assay range and sensitivity depend on the specific kit used. Accurate interpretation requires comparing the sample values to the standard curve to assess Tenascin-C expression levels, which can provide insights into the biological or pathological state being investigated.
  21. Sample Size This clinical trial aims to compare the effectiveness of Robotic Therapy, Exergame Therapy, and Standard Therapy in improving hand function among post-stroke patients. Assuming a standard deviation of 26.75, an expected mean difference of 18.72, and a dropout rate of 30%, the sample size is calculated to be 16 participants per group. This calculation is based on a 95% confidence level (Zα = 1.96) and 80% power (Zβ = 0.84) across the three arms.
  22. Proposed Statistical Analysis the data will be analyzed using Analysis of Variance/ ANOVA assuming no difference in baseline characteristic. Next, the relationship between continuous values will be assessed using the Pearson correlation test (normally distributed data) or the Spearman test (data not normally distributed) to determine how big the correlation is between these variables.
Being tested
Exergame, Robotic, Conventional
Keywords
Robotic Rehabilitation, Video-assisted Rehabilitation, Post-Stroke, Functional Outcome, Tenascin-C
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExergameProcedure or surgery

    Hand Training assisted with Virtual-Reality

  • RoboticProcedure or surgery

    Hand Training assisted with Robotic Syrebo

  • ConventionalProcedure or surgery

    Hand Training with Physical Therapist

Study groups in NCT06563206
Study groupRoleWhat they receive
Standard Rehabilitation/ConventionalActive comparatorThe conventional exercise therapy group will be given diathermic, electricity modality, hydrotherapy, and therapeutic exercises in the form of muscle stretching, strengthening exercises, transfer exercises, walking exercises, and hand function exercises for 3 times a week within 6 weeks.
Receives: Procedure: Conventional
ExergameExperimentalConventional therapy coupled with virtual reality Exergame exercises on the hands for 3 times a week a time 6 weeks
Receives: Procedure: Exergame
RoboticExperimentalconventional therapy coupled with robotic therapy exercises on the hands for 3 times a week a time of 6 weeks
Receives: Procedure: Robotic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Assessment Upper Extremity (FMA-EU) Score

    a motoric assessment with each score range from 0-2 with a total score range from 0-66. Higher score indicates better and free movement

    Measured: changes of FMA-UE score from pre-intervention to six weeks after intervention

  2. Nine Hole Peg Test Value

    an assessment for finger dexterity and coordination where the time of the subject to accomplish task will be recorded. Average healthy adult male completed the NHPT in 19.0 seconds (SD 3.2) with the right hand, and in 20.6 seconds (SD 3.9) with the left hand. For healthy adult women, the NHPT was completed in 17.9 seconds (SD 2.8) and 19.6 seconds (SD 3.4) with the right and left hands, respectively.

    Measured: changes of NHPT values from pre-intervention to six weeks after intervention

  3. Handgrip Dynamometer value

    The handgrip dynamometer measures hand strength, with a typical range of 0 to 100 kg (0 to 220 lb). For men, normal handgrip strength usually falls between 30-60 kg (66-132 lb), while for women it ranges from 20-40 kg (44-88 lb).

    Measured: changes of handgrip values from pre-intervention to six weeks after intervention

  4. Tenascin-C value

    The normal range of Tenascin-C levels in healthy individuals typically falls between 50 to 200 ng/mL.

    Measured: changes of Tenascin-C value from pre-intervention to six weeks after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2024
  2. Study start1 Oct 2023
  3. Primary completion1 Dec 2024 (estimated)
  4. Study completion1 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study will be conducted using parallel design of three different rehabilitation approach with repeated measurements of outcomes, before and after intervention.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06563206
Sponsor's protocol ID
0208242322
Status last verified
Aug 2024
First submitted
17 Aug 2024
Last updated
20 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No To protect the confidentiality, should the data need to share, any de-identified data will be shared for peer-review

Questions about this trial

What is this clinical trial studying?

A study testing Exergame, Robotic and Conventional in people with Stroke and Paralysis Arm, run by Hasanuddin University at 2 sites in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Auliyah Fadly, MD (+6281234328649, muh.auliyah.fadly@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Assessment Upper Extremity (FMA-EU) Score (time frame: changes of FMA-UE score from pre-intervention to six weeks after intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in